We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Pfizer recently submitted a citizen petition calling on the FDA to issue guidance that will ensure companies use "truthful and non-misleading" communications regarding the safety and effectiveness of biosimilars compared to the originator products.